Molecular hydrogen consumption in the human body during the inhalation of hydrogen gas.
Akito Shimouchi, Kazutoshi Nose, Tomoe Mizukami, Dock-Chil Che, Mikiyasu Shirai · Advances in experimental medicine and biology · 2013
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined the available evidence on molecular hydrogen. As a result, was found to be approximately 0.7 μmol/min/m(2)BSA, which was compatible with the findings the researchers obtained using H₂-rich water. This publication is a scholarly chapter or synthesis and should be interpreted as related background science rather than as a standalone controlled therapeutic trial. The reviewed evidence supports molecular hydrogen's therapeutic potential. Additional well-designed studies are needed to clarify clinical safety and effectiveness.
What the Review Examined
The review examined molecular hydrogen consumption in the human body during the inhalation of hydrogen gas.
Main Findings Across the Literature
Inhaling or ingesting hydrogen (H₂) gas improves oxidative stress-induced damage in animal models and humans. To confirm this result, the researchers evaluated [Formula: see text]during the inhalation of low levels of H₂ gas.
H₂ Mechanisms / Biological Findings
Inhaling or ingesting hydrogen (H₂) gas improves oxidative stress-induced damage in animal models and humans.
Authors’ Conclusion
A distinct authors’ conclusion was not available in the source material reviewed by H2HUBB.
Areas of Agreement or Uncertainty
This publication is a scholarly chapter or synthesis and should be interpreted as related background science rather than as a standalone controlled therapeutic trial.
Limitations Reported by the Authors
This publication is a scholarly chapter or synthesis and should be interpreted as related background science rather than as a standalone controlled therapeutic trial.